Technology areas: Chemistry & Materials • Medical Devices & Mechanical Engineering
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Foldax Inc. is currently managing a company patent portfolio in the Medical Devices & Mechanical Engineering technology area. The portfolio has 3 pending office actions, which are distributed across 2 distinct art units. This indicates that the company's innovations are being evaluated by multiple specialized groups within the USPTO, requiring a coordinated prosecution strategy.
The 3 pending office actions are being reviewed by 3 distinct examiners, meaning each application has a unique point of contact. NERENBERG, RENEE FLORENCIA is identified as the busiest examiner, currently holding 1 busiest examiner pending office action. For a practitioner, this distribution means that no single examiner dominates the portfolio, and the 3 distinct examiners may each bring different perspectives to the 2 distinct art units involved.
Successful management of the Foldax Inc. portfolio requires addressing the specific concerns of NERENBERG, RENEE FLORENCIA and the other two officials. Since the 3 pending office actions are spread across 2 distinct art units, there may be some technical overlap, but the individual examiner preferences will be the primary factor in achieving allowance. Practitioners should monitor the 3 distinct examiners for any diverging trends in the Medical Devices & Mechanical Engineering space.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NERENBERG, RENEE FLORENCIA | 1 | 66.7% | +0.0% |
| GANESAN, SUBA | 1 | 73.8% | +13.4% |
| BOWMAN, ANDREW J | 1 | 65.9% | +13.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18835852 | TRANSCATHETER VALVE INTRODUCER SYSTEM AND METHODS | NERENBERG, RENEE FLORENCIA | — |
| 18133389 | REPLACEMENT HEART VALVES AND THEIR METHODS OF USE AND MANUFACTURE | GANESAN, SUBA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16054631 | SYSTEMS, DEVICES, AND METHODS RELATING TO THE MANUFACTURE OF PROSTHETIC VALVES | BOWMAN, ANDREW J | 39d |
| 18133389 | REPLACEMENT HEART VALVES AND THEIR METHODS OF USE AND MANUFACTURE | GANESAN, SUBA | — |
| Art Unit | Apps |
|---|---|
| 3774 | 1 |
| 1717 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18835852 | TRANSCATHETER VALVE INTRODUCER SYSTEM AND METHODS | NERENBERG, RENEE FLORENCIA | — | §103§112 | Non-Final OA | — | Pending | Aug 05, 2024 |
| 18133389 | REPLACEMENT HEART VALVES AND THEIR METHODS OF USE AND MANUFACTURE | GANESAN, SUBA | 3774 | §103§112 | Non-Final OA | — | Pending | Apr 11, 2023 |
| 16054631 | SYSTEMS, DEVICES, AND METHODS RELATING TO THE MANUFACTURE OF PROSTHETIC VALVES | BOWMAN, ANDREW J | 1717 | §103 | Non-Final OA | 39d | Pending | Aug 03, 2018 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial